Z-0854-2022Class II
Illumina NextSeq 550Dx, REF: 20005715, CE, IVD
Illumina, Inc. / initiated 2022-02-22 / Completed / root cause: design
Illumina, Inc. began a recall of Illumina NextSeq 550Dx, REF: 20005715, CE, IVD on . FDA classified it as Class II and gives the reason as "There is a potential that the DNA sequence analyzer may short circuit shortly after disconnection and reconnection of circuit board or imaging module due to an insufficient reconnection of the ribbon cable. The short...". As of , the recall status on record is Completed, and MDM tags the root cause as design.
Recall record
- Recall number
- Z-0854-2022
- Classification
- Class II
- Status
- Completed
- Initiated
- Posted
- Recalling firm
- Illumina, Inc.
- Product
- Illumina NextSeq 550Dx, REF: 20005715, CE, IVD
- Product code
- PFF High Throughput Dna Sequence Analyzer
- Reason for recall
- There is a potential that the DNA sequence analyzer may short circuit shortly after disconnection and reconnection of circuit board or imaging module due to an insufficient reconnection of the ribbon cable. The short circuit results in the device being inoperable.
- Root cause tag
- design
- FDA root cause
- Device Design
- Action
- On February 22, 2022 Illumina issued a "Urgent Field Safety" recall notice to all affected consignees via E-Mail. The firm issued an amended "Urgent Medical Device" recall notice on March 11, 2022 via email to provide consignees with additional information. In addition to notifying consignees about the recall, the firm asked consignees to take the following actions: 1. Complete the attached FSN2022-125 verification form to confirm receipt of the notification and return the form to Technical Support at [email protected] within 5 business days. 2. If you have not already sent Illumina the Verification Form attached to FSN2022-1215, please complete the attached copy of the form and return it to Technical Support at [email protected] within 5 business days. No additional action is required at this time 3. Please note, if an operator experiences an adverse event with the use of this product, user may report this to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Quantity in commerce
- 674 instruments
- Distribution
- US: PA, WA, CA, MI, FL, MD, AR, UT NC, Fl, IL, NE, NJ, TN, NY, IN, CO, GA, OK, TX, CT, SD, NM, VA, AL, LA, SC, WV, OR, IA, AZ, MN OUS: Australia Austria Belgium Chile China Denmark Finland France Germany Hungary Ireland Italy Japan Latvia Netherlands Norway Poland Portugal Romania Russian Federation Saudi Arabia Singapore Slovakia South Africa South Korea Spain Sweden Switzerland Turkey United Arab Emirates United Kingdom Vietnam
- Product codes and lots
- Lot #s NDX550110 - NDX550843 ; UDI: (01)00816270020125
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0854-2022 | Class II | Completed | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
